Clinical Trials Directory

Trials / Completed

CompletedNCT05487183

Test Retest Reliability of OA and OH

Test Retest Reliability of Offset Analgesia and Onset Hyperalgesia Paradigm

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
74 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The goal of this study is to measure the test retest reliability of offset analgesia (OA) and onset hyperalgesia (OH) across multiple study visits. OA and OH are quantitative sensory tests (QST) thought to measure how the brain modulates pain. This study will use a heat thermode to induce OA and OH in healthy, pain-free volunteers across 3 study visits. Additional QST measures and survey data relevant to pain modulation will be collected. This study lays the foundation required to use OA and OH as tools to measure pain modulation in clinical trials. Following their validation, we anticipate that OA and OH will serve as predictive and therapeutic biomarkers, which will aid both in the development of novel analgesics and in treatment selection leading to the personalization of pain management.

Conditions

Interventions

TypeNameDescription
BEHAVIORALMedoc cutaneous probeA computer-controlled probe delivers temperatures to the skin to measure pain, OA, and OH
BEHAVIORALQuantitative sensory testingStandard methods involving pinprick, pressure, heat, and cold applied to the skin are used to measure sensation and pain
BEHAVIORALComputer tasksQST and computer tasks are used to measure changes in pain intensity

Timeline

Start date
2022-08-05
Primary completion
2024-04-10
Completion
2024-04-10
First posted
2022-08-04
Last updated
2024-06-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05487183. Inclusion in this directory is not an endorsement.